Transgene Biotek Ltd.    

 
BOMBAY: TRABI

Address:

Plot 68, 69, and 70, IDA Bollaram

Andhra Pradesh, 502 325

India

Phone:
918458 279103

Fax:
918458 279755


Company description

Manufacturing: Manufacture of gene therapy products, diagnostic kits and research and development of medical reagents.

Log in for comprehensive information about this and hundreds of thousands of other companies.

News and information about Transgene Biotek Ltd.

Fixes Book Closure for AGM (SCRIPCODE: 526139)
Accord Fintech; August 17, 2017; 231 words
India, Aug. 17 -- Transgene Biotek Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2017...
Board Meeting Intimation for Results & Closure of Trading Window (SCRIPCODE: 526139)
Accord Fintech; November 9, 2016; 293 words
India, Nov. 9 -- Transgene Biotek Ltd has informed BSE that a meeting of the Board of Directors will be held on November 14, 2016, to transact the following business...
Board Meeting on Sept 02, 2016 (SCRIPCODE: 526139)
Accord Fintech; August 23, 2016; 270 words
India, Aug. 23 -- Transgene Biotek Ltd has informed BSE that a meeting of the Board of Directors will be held on September 02, 2016:1. To approve Directors? Report...
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter Ended March 31, 2016 (SCRIPCODE: 526139)
Accord Fintech; April 7, 2016; 236 words
India, April 7 -- Transgene Biotek Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March...
Board Intimation for Results & Closure of Trading Window (SCRIPCODE: 526139)
Accord Fintech; January 30, 2016; 294 words
India, Jan. 30 -- Transgene Biotek Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 15, 2016, to transact the...
Transgene Biotek Informs about Closure of Trading Window
Accord Fintech; January 30, 2016; 288 words
India, Jan. 30 -- Transgene Biotek has informed that the meeting of the Board of Directors of the Company will be held on February 15, 2016, to take on record the...
Transgene Biotek Informs about Quarterly Statement of Investor Complaint
Accord Fintech; January 13, 2016; 236 words
India, Jan. 13 -- Transgene Biotek has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31...
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 (SCRIPCODE: 526139)
Accord Fintech; January 13, 2016; 231 words
India, Jan. 13 -- Transgene Biotek Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December...

Search HighBeam Business for more news about Transgene Biotek Ltd.

Industry information

NAICS codes 
North American Industry Classification System (NAICS) codes are used to classify businesses for the purpose of collecting statistical data related to the U.S. economy. NAICS codes have been assigned to international companies to help organize all companies by type of activity.  

Primary: 325413 - In-Vitro Diagnostic Substance Manufacturing


 

SIC codes 
Standard Industrial Classification (SIC) codes classify establishments by their primary type of activity. SIC codes are a U.S. Census Bureau system but can apply to international companies.  

Primary: 2835 - In Vitro and In Vivo Diagnostic Substances industry report